Fulcrum Therapeutics shares owned by Wells Fargo & Company
Quarter-by-quarter ownership of Fulcrum Therapeutics (FULC) shares owned by Wells Fargo & Company
from 13F filings
Historical chart of Wells Fargo & Company investment in Fulcrum Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Fulcrum Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Fulcrum Therapeutics by Wells Fargo & Company
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $299k | 33k | 9.20 |
| 2025-06-30 | $232k | 34k | 6.88 |
| 2025-03-31 | $88k | 31k | 2.88 |
| 2024-12-31 | $161k | 34k | 4.70 |
| 2024-09-30 | $91k | 26k | 3.57 |
| 2024-06-30 | $156k | 25k | 6.20 |
| 2024-03-31 | $3.7k | 387 | 9.44 |
| 2023-12-31 | $2.6k | 381 | 6.75 |
| 2023-09-30 | $1.6k | 361 | 4.44 |
| 2023-06-30 | $3.2k | 965 | 3.30 |
| 2022-12-31 | $23k | 3.2k | 7.28 |
| 2022-09-30 | $65k | 5.6k | 11.63 |
| 2022-06-30 | $29k | 5.9k | 4.88 |
| 2022-03-31 | $332k | 14k | 23.63 |
| 2021-12-31 | $404k | 23k | 17.69 |
| 2021-09-30 | $164k | 5.9k | 28.01 |
| 2021-06-30 | $83k | 7.9k | 10.52 |
| 2021-03-31 | $111k | 9.3k | 11.85 |
| 2020-12-31 | $221k | 19k | 11.73 |
| 2020-09-30 | $117k | 15k | 7.89 |
| 2020-06-30 | $280k | 15k | 18.27 |
| 2020-03-31 | $109k | 9.1k | 11.98 |
| 2019-12-31 | $33k | 2.0k | 16.77 |
| 2019-09-30 | $2.0k | 364 | 5.49 |